Clinical Trial Update: A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers [Phase 4]

View source ↗

Summary

A Phase 4 feasibility study evaluating the ReGenerCell Autologous Cell Harvesting Device for diabetic foot ulcers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ReGenerCell

Snippet

Sponsor: Avita Medical | Conditions: Diabetic Foot Ulcer | Phase 4 | Status: COMPLETED